Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Zoledronic Acid”

323 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 323 results

Large-scale testing (Phase 3)Ended earlyNCT00130494
What this trial is testing

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions

Who this might be right for
Breast CancerNeoplasm Metastasis
Spanish Breast Cancer Research Group 97
Large-scale testing (Phase 3)Study completedNCT01656512
What this trial is testing

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

Who this might be right for
Osteoporosis
Children's Cancer Hospital Egypt 57357 95
Post-approval studies (Phase 4)Study completedNCT00622505
What this trial is testing

Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 121
Testing effectiveness (Phase 2)Study completedNCT03336983
What this trial is testing

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

Who this might be right for
Prostate CancerBone Metastases
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 126
Large-scale testing (Phase 3)UnknownNCT02622607
What this trial is testing

Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer

Who this might be right for
Lung Cancer
Tang-Du Hospital 200
Early research (Phase 1)Ended earlyNCT00278434
What this trial is testing

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Who this might be right for
Cervical CancerPrecancerous Condition
University of California, San Francisco 12
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Post-approval studies (Phase 4)Study completedNCT03424239
What this trial is testing

Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery

Who this might be right for
Bariatric Surgery Candidate
Massachusetts General Hospital 6
Testing effectiveness (Phase 2)Looking for participantsNCT04608630
What this trial is testing

Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Who this might be right for
Critical IllnessOsteoporosis
Australian and New Zealand Intensive Care Research Centre 450
Large-scale testing (Phase 3)Ended earlyNCT03040765
What this trial is testing

Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)Osteoporosis
Hamad Medical Corporation 17
Not applicableWithdrawnNCT02069340
What this trial is testing

Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid

Who this might be right for
Malignant NeoplasmMusculoskeletal Complications
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT00301873
What this trial is testing

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Who this might be right for
Brain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies
Duke University 60
Not applicableStudy completedNCT01062503
What this trial is testing

Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC

Who this might be right for
Metastatic Prostate CancerBone Metastasis
University Health Network, Toronto 48
Post-approval studies (Phase 4)Looking for participantsNCT07281586
What this trial is testing

Step-down Therapy After Long-term Osteoporosis Treatment

Who this might be right for
Osteoporosis
National Taiwan University Hospital 44
Large-scale testing (Phase 3)Study completedNCT00046254
What this trial is testing

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Who this might be right for
OsteoporosisHip Fracture
Novartis Pharmaceuticals 2,127
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Post-approval studies (Phase 4)Study completedNCT00164008
What this trial is testing

Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention

Who this might be right for
OsteopeniaComplications of Heart-lung TransplantOther Complications of Lung Transplant
Bayside Health 56
Large-scale testing (Phase 3)UnknownNCT02504008
What this trial is testing

CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1

Who this might be right for
Complex Regional Pain SyndromeReflex Sympathetic Dystrophy
Axsome Therapeutics, Inc. 190
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Early research (Phase 1)Study completedNCT00742924
What this trial is testing

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 24
Next Page